 |
|
Preenucleation Radiotherapy, Uveal Melanoma, and Competing Risks—Reply
Emine Kilic, MD, PhD;
Theo Stijnen, PhD;
Gre P. M. Luyten, MD, PhD
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In reply
In the October 2005 issue of the Archives, we reported that preenucleation external beam radiotherapy has a beneficial effect on survival of patients with uveal melanoma.1 Survival after 4 years of follow-up was better in the PER group. Death due to all causes and melanoma-related death were compared between PER and EO, corrected for age and other potential confounders. Unadjusted survival curves were given as a graphical illustration. In both analyses, the risk of death was significantly lower from 4 years onward in the PER group.
Kivelä and Kujala observe that our results differ from those of the Collaborative Ocular Melanoma Study2 and suggest that this might be owing to our statistical analysis being possibly biased. Unfortunately, we disagree. Kivelä and Kujala are not critical with respect to our results for death due to . . . [Full Text of this Article]
AUTHOR INFORMATION
RELATED ARTICLE
Reduced Melanoma-Related Mortality in Uveal Melanoma by Preenucleation Radiotherapy
Emine Kilic, Theo Stijnen, Paulus T. V. M. de Jong, Cornelia M. Mooy, Wilhelmina M. H. Eijkenboom, Peter J. Ringens, and Gre P. M. Luyten
Arch Ophthalmol. 2005;123(10):1363-1367.
ABSTRACT
| FULL TEXT
RELATED LETTERS
Pulmonary Metastasis Masquerading as Anterior Uveitis
Muge R. Kesen, Deepak P. Edward, Lawrence J. Ulanski, Howard H. Tessler, and Debra A. Goldstein
Arch Ophthalmol. 2008;126(4):572-574.
EXTRACT
| FULL TEXT
Preenucleation Radiotherapy, Uveal Melanoma, and Competing Risks
Tero Kivelä and Emma Kujala
Arch Ophthalmol. 2008;126(4):580-581.
EXTRACT
| FULL TEXT
|
